C-reactive protein point-of-care testing for safely reducing antibiotics for acute exacerbations of chronic obstructive pulmonary disease: the PACE RCT

C-reactive protein point-of-care testing for safely reducing antibiotics for acute exacerbations of chronic obstructive pulmonary disease: the PACE RCT

Background: Most patients presenting with acute exacerbations of chronic obstructive pulmonary disease (AECOPD) in primary care are prescribed antibiotics, but these may not be beneficial, and they can cause side effects and increase the risk of subsequent resistant infections. Point-of-care tests (...

Full description

Bibliographic Details
Main Authors: Nick A Francis, David Gillespie, Patrick White, Janine Bates, Rachel Lowe, Bernadette Sewell, Rhiannon Phillips, Helen Stanton, Nigel Kirby, Mandy Wootton, Emma Thomas-Jones, Kerenza Hood, Carl Llor, Jochen Cals, Hasse Melbye, Gurudutt Naik, Micaela Gal, Deborah Fitzsimmons, Mohammed Fasihul Alam, Evgenia Riga, Ann Cochrane, Christopher C Butler
Format: Article
Language:English
Published: NIHR Journals Library 2020-03-01
Series:Health Technology Assessment
Subjects:
chronic obstructive pulmonary disease
primary care
point-of-care testing
c-reactive
protein
antimicrobial stewardship
cost-effectiveness
antibacterial agents
randomised controlled trial
Online Access:https://doi.org/10.3310/hta24150

Internet

https://doi.org/10.3310/hta24150

Similar Items